http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210090147-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a6e0ea986466fcb5b6621fa67f6f8d |
| publicationDate | 2021-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210090147-A |
| titleOfInvention | Markers for diagnosing prognosis of patient of clear cell renal cell carcinoma |
| abstract | The present invention relates to a marker for prognostic diagnosis of kidney cancer patients. In kidney cancer patients, since the mutation of the gene of the present invention and the survival rate of the patient, or the mutation of the gene of the present invention and the recurrence rate of kidney cancer are respectively correlated, kidney cancer Variants of the genes of the present invention can be used as markers to predict the prognosis of a patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230080281-A |
| priorityDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1122.